PharmSync
ActiveSummary
PharmSync has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €104,589 and a net result of €57,846. Its solvency ranks better than 79% of 13,365 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 0.3% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
31-08
NBB filing
Annual accounts filed
financial year 2025 · micro format · 31 days late
2025
31-12
Financial
Equity above €100,000equity €104,589 ▲124%
A profit in every financial year since 2024 builds equity to €104,589.
29-07
NBB filing
Annual accounts filed
financial year 2024 · micro format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 1 deed read
About the unread acts
We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.